Related Experiment Video
Updated: Oct 13, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19. A Systematic Review and Meta-Analysis
Hans-Jonas Meyer1, Andreas Wienke2, Alexey Surov3
1Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany.
Insights
Thoracic computed tomography (CT) identified non-pulmonary findings like pleural effusion, coronary calcification, and mediastinal lymphadenopathy are associated with increased in-hospital mortality in COVID-19 patients. These findings can serve as prognostic biomarkers.
Area of Science:
- Radiology
- Pulmonology
- Infectious Diseases
Background:
- COVID-19 prognosis is influenced by various factors.
- Non-pulmonary findings on thoracic CT scans may impact patient outcomes.
- Identifying reliable prognostic markers is crucial for managing COVID-19 patients.
Purpose of the Study:
- To investigate the association between extrapulmonary findings on thoracic CT and unfavorable outcomes, including in-hospital mortality, in COVID-19 patients.
- To evaluate the prognostic value of specific CT-identified extrapulmonary features.
Main Methods:
- A systematic review and meta-analysis of studies published up to June 2021.
- Screening of MEDLINE, Cochrane, and SCOPUS databases for relevant studies.
- Pooled analysis of data from 22 studies including 7859 COVID-19 patients.
Main Results:
- Pleural effusion (OR 4.60), coronary calcification (OR 2.68), and mediastinal lymphadenopathy (OR 2.02) were significantly associated with increased in-hospital mortality.
- Pericardial effusion showed a non-significant trend towards increased mortality (OR 1.29).
Conclusions:
- Pleural effusion, mediastinal lymphadenopathy, and coronary calcification are significant predictors of in-hospital mortality in COVID-19.
- These CT-identified extrapulmonary findings should be considered as prognostic biomarkers in clinical practice.
Rationale And Objectives:
Several prognostic factors have been identified for COVID-19 disease. Our aim was to elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample.
Materials And Methods:
MEDLINE library, Cochrane and SCOPUS databases were screened for the associations between CT-defined features and mortality in COVID-19 patients up to June 2021. In total, 22 studies were suitable for the analysis, and included into the present analysis. Overall, data regarding 4 extrapulmonary findings could be pooled: pleural effusion, pericardial effusion, mediastinal lymphadenopathy, and coronary calcification.
Results:
The included studies comprised 7859 patients. The pooled odds ratios for the effect of the identified extrapulmonary findings on in-hospital mortality are as follows: pleural effusion, 4.60 (95% CI 2.97-7.12); pericardial effusion, 1.29 (95% CI 0.83-1.98); coronary calcification, 2.68 (95% CI 1.78-4.04); mediastinal lymphadenopathy, 2.02 (95% CI 1.18-3.45).
Conclusion:
Pleural effusion, mediastinal lymphadenopathy and coronary calcification have a relevant association with in-hospital mortality in COVID-19 patients and should be included as prognostic biomarker into clinical routine.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumonia III: Complications and Assessment
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

